QURE (STOCKS)
uniQure N.V.
$28.200000
+0.630000 (+2.29%)
Prev close: $27.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Matthew C. Kapusta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,740.82M
- Employees
- 209
- P/E (TTM)
- -7.93
- P/B (TTM)
- 11.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.85 | $-0.89 | +0.0436 | +4.88% |
|
Dec 2025 (Q4)
|
$-0.64 | $-0.97 | +0.3251 | +33.69% |
|
Sep 2025 (Q3)
|
$-1.38 | $-0.92 | -0.4624 | -50.39% |
|
Jun 2025 (Q2)
|
$-0.69 | $-0.91 | +0.2221 | +24.35% |
Financial Statements
| Revenues | $18.09M |
| Benefits Costs and Expenses | $221.34M |
| Cost Of Revenue | $1.71M |
| Costs And Expenses | $210.03M |
| Gross Profit | $16.39M |
| Operating Expenses | $208.12M |
| Selling, General, and Administrative Expenses | $74.62M |
| Depreciation and Amortization | $13.19M |
| Research and Development | $133.71M |
| Operating Income/Loss | -$191.74M |
| Other Operating Income/Expenses | $2.13M |
| Income/Loss From Continuing Operations After Tax | -$208.87M |
| Income/Loss From Continuing Operations Before Tax | -$203.25M |
| Income Tax Expense/Benefit | $5.62M |
| Income Tax Expense/Benefit, Deferred | $1.59M |
| Net Income/Loss | -$208.87M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$208.87M |
| Net Income/Loss Available To Common Stockholders, Basic | -$208.87M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.48 |
| Diluted Earnings Per Share | -$3.48 |
| Basic Average Shares | 177,688,979 |
| Diluted Average Shares | 177,688,979 |
| Assets | $778.71M |
| Current Assets | $615.74M |
| Prepaid Expenses | $16.59M |
| Other Current Assets | $599.16M |
| Noncurrent Assets | $162.96M |
| Fixed Assets | $12.01M |
| Intangible Assets | $69.99M |
| Other Non-current Assets | $80.96M |
| Liabilities | $629.36M |
| Current Liabilities | $59.20M |
| Accounts Payable | $4.40M |
| Wages | $10.13M |
| Other Current Liabilities | $44.67M |
| Noncurrent Liabilities | $570.17M |
| Equity | $149.34M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $149.34M |
| Liabilities And Equity | $778.71M |
| Net Cash Flow From Operating Activities | -$172.11M |
| Net Cash Flow From Operating Activities, Continuing | -$172.11M |
| Net Cash Flow From Investing Activities | -$243.16M |
| Net Cash Flow From Investing Activities, Continuing | -$243.16M |
| Net Cash Flow From Financing Activities | $335.28M |
| Net Cash Flow From Financing Activities, Continuing | $335.28M |
| Exchange Gains/Losses | $2.87M |
| Net Cash Flow | -$77.12M |
| Net Cash Flow, Continuing | -$79.99M |
| Comprehensive Income/Loss | -$214.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$214.95M |
| Other Comprehensive Income/Loss | -$124.33M |
| Other Comprehensive Income/Loss Attributable To Parent | -$6.08M |